Lv5
1020 积分 2023-06-12 加入
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study
11小时前
求助中
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
25天前
已完结
Amivantamab plus lazertinib vs osimertinib in first-line (1L) EGFR-mutant (EGFRm) advanced NSCLC: Final overall survival (OS) from the phase III MARIPOSA study
1个月前
已关闭
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
1个月前
已完结
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck A Randomized Clinical Trial
1个月前
已完结
Curative Application of Immunotherapy in Untreated Head and Neck and Nasopharynx Cancer
1个月前
已完结
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma The DIPPER Randomized Clinical Trial
1个月前
已完结
vonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study
1个月前
已关闭
Comparison Of Hybrid Capture 2 Oncogenic HPV Test Performance On Evalyn- Vs Qiagen-Brush Self-Collected Specimens Among A South African Population Enriched For HIV-Positivity
2个月前
已关闭
皖公网安备34019202002308
